Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding and Linkage00:49

Ligand Binding and Linkage

5.4K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.4K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

3.9K
3.9K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

14.7K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.7K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

444
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
444
Ligand Binding Sites02:40

Ligand Binding Sites

14.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.7K
Ligand Binding Sites02:40

Ligand Binding Sites

8.5K
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling the Antiviral Efficacy of Surfactants: Deactivation of Nonenveloped Viruses through Synergistic Electrostatic Mechanisms.

ACS nano·2026
Same author

Adaptive Machine Learning Framework for Optimizing the Affinity Purification of Adeno-Associated Viral Vectors.

Biotechnology and bioengineering·2026
Same author

Effect of cell retention techniques in Komagataella phaffii lab-scale continuous processes.

Biotechnology progress·2025
Same author

Developing a process of lentivirus purification from recombinant fluids using peptide affinity ligands.

Bioengineering & translational medicine·2025
Same author

Development of Peptide Glucosyltransferase Inhibitors With Comprehensive Coverage Across Clostridioides difficile Toxin B Sub-Types.

Biotechnology and bioengineering·2025
Same author

Affinity Peptides With pH Sensitivity for the Enrichment of CD38<sup>+</sup> Cells.

Biotechnology and bioengineering·2025

Related Experiment Video

Updated: Dec 20, 2025

Affinity Labeling Detection of Endogenous Receptors from Zebrafish Embryos
08:39

Affinity Labeling Detection of Endogenous Receptors from Zebrafish Embryos

Published on: August 31, 2016

6.0K

Affibody-Binding Ligands.

Annalisa Barozzi1, R Ashton Lavoie1, Kevin N Day1

  • 1Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695-7905, USA.

International Journal of Molecular Sciences
|May 31, 2020
PubMed
Summary
This summary is machine-generated.

Researchers developed affibody-binding peptides for purifying small protein scaffolds called affibodies from bacterial lysates. The IGKQRI peptide demonstrated effective purification, showing high binding capacity and purity for affibody-based therapeutics.

Keywords:
affibodyaffinity chromatographybiomanufacturingpeptide ligandsprotein purification

More Related Videos

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
15:27

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

21.4K
Fluorescence Biomembrane Force Probe: Concurrent Quantitation of Receptor-ligand Kinetics and Binding-induced Intracellular Signaling on a Single Cell
14:09

Fluorescence Biomembrane Force Probe: Concurrent Quantitation of Receptor-ligand Kinetics and Binding-induced Intracellular Signaling on a Single Cell

Published on: August 4, 2015

12.9K

Related Experiment Videos

Last Updated: Dec 20, 2025

Affinity Labeling Detection of Endogenous Receptors from Zebrafish Embryos
08:39

Affinity Labeling Detection of Endogenous Receptors from Zebrafish Embryos

Published on: August 31, 2016

6.0K
Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
15:27

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

21.4K
Fluorescence Biomembrane Force Probe: Concurrent Quantitation of Receptor-ligand Kinetics and Binding-induced Intracellular Signaling on a Single Cell
14:09

Fluorescence Biomembrane Force Probe: Concurrent Quantitation of Receptor-ligand Kinetics and Binding-induced Intracellular Signaling on a Single Cell

Published on: August 4, 2015

12.9K

Area of Science:

  • Biotechnology
  • Protein Engineering
  • Affinity Chromatography

Background:

  • Antibodies are established tools, but alternative protein scaffolds like affibodies offer advantages.
  • Affibodies are small proteins with tunable affinity, low immunogenicity, and high expression.

Purpose of the Study:

  • To develop novel peptide ligands for efficient purification of affibodies from bacterial lysates.
  • To identify peptides that target conserved domains within affibody structures.

Main Methods:

  • Screening a peptide library against model affibodies (anti-IgG, anti-albumin).
  • Synthesizing selected peptides on resin and evaluating binding capacity and recovery.
  • In silico docking to confirm interaction with conserved affibody domains.
  • Validating the IGKQRI ligand for anti-ErbB2 affibody purification from E. coli lysate.

Main Results:

  • Identified affibody-binding peptide candidates targeting conserved domains.
  • The IGKQRI ligand demonstrated high binding capacity (~5 mg/mL), affinity (KD ~1 μM), and purity (86-91%).
  • The resin showed a long lifetime (100 cycles) and good recovery (64-71%).

Conclusions:

  • The IGKQRI peptide is a viable ligand for affibody purification via affinity chromatography.
  • This development facilitates the production of affibody-based bio-analytic reagents and therapeutics.
  • Peptide ligands offer a promising alternative for protein purification processes.